Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Tempus AI Inc TEM

Healthcare Biotechnology
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and... see more

Current News (NDAQ:TEM)

Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research

Business Wire 2 days ago

Tempus Announces Six Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer Annual Meeting 2025

Business Wire 11 days ago

Tempus Reports Third Quarter 2025 Results

Business Wire 12 days ago

Tempus to Participate in the Stifel 2025 Healthcare Conference

Business Wire October 28, 2025

Tempus to Report Third Quarter 2025 Financial Results on November 4

Business Wire October 21, 2025

Ambry Genetics Announces 10-Year Study in Genetics in Medicine Highlighting the Impact of Proactive Exome Reanalysis for Healthcare Equity

Business Wire October 20, 2025

Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research

Business Wire October 16, 2025

Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025

Business Wire October 15, 2025

Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy

Business Wire October 9, 2025
View More News ››

Opinion & Analysis (NDAQ:TEM)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:TEM)

RE:long term this stock is great...

Agreed, a really interesting company
throwaway11 - October 26, 2025

long term this stock is great...

I would load up on this one...
pennymaker69 - May 13, 2025
View more Bullboard ››

Kobrea Exploration Corp.

Kobrea Exploration Corp.

Kobrea Exploration Corp. is a Canada-based mineral exploration and development company focused on the acquisition and ...
View More »